Company / Operating Income per Share
Relay Therapeutics, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.80
FY2025
5-year range
-$3.08 / -$0.52
FY2021-FY2025
Trend
+38.2%
vs FY2024
Sector context
#109 of 201
Health Care
What the data says
At $-1.80, Relay Therapeutics, Inc.'s operating income per share ranks #109 of 201 in the Health Care sector. Improved from $-3.08 to $-1.80 over the past 2 years.
Based on SEC 10-K filings.
-1.80 in FY2025.
Improved from $-3.08 to $-1.80 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 201 in Health CareTop 54% of 201This company -$1.80 Sector average -$3.23
▼
+44.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 38.2% year-over-year.
- Ranks #109 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.80 | +38.2% |
| FY2024 | -$2.92 | +5.1% |
| FY2023 | -$3.08 | -497.3% |
| FY2022 | -$0.52 | +44.8% |
| FY2021 | -$0.93 | +95.5% |
| FY2020 | -$20.82 | +14.5% |
| FY2019 | -$24.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026